vinpocetine has been researched along with Amentia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Srivastava, PK; Thakkar, HP | 1 |
| Chang, YC; Perng, CH; Tzang, RF | 1 |
| Gu, PF; Li, Y; Shang, Y; Wang, L | 1 |
| Csányi, A; Németh, L; Valikovics, A | 1 |
| Szatmari, SZ; Whitehouse, PJ | 1 |
| Kidd, PM | 1 |
| Braun, W; Frercks, HJ; Grandt, R; Lührmann, B; Schulz, HU | 1 |
3 review(s) available for vinpocetine and Amentia
| Article | Year |
|---|---|
The treatment of cognitive dysfunction in dementia: a multiple treatments meta-analysis.
Topics: Alzheimer Disease; Clinical Trials as Topic; Cognitive Dysfunction; Combined Modality Therapy; Complementary Therapies; Dementia; Donepezil; Ginkgo biloba; Humans; Plant Extracts; Treatment Outcome; Vinca Alkaloids | 2018 |
Vinpocetine for cognitive impairment and dementia.
Topics: Alzheimer Disease; Cognition Disorders; Dementia; Dementia, Vascular; Humans; Nootropic Agents; Randomized Controlled Trials as Topic; Vinca Alkaloids | 2003 |
A review of nutrients and botanicals in the integrative management of cognitive dysfunction.
Topics: Acetylcarnitine; Cognition Disorders; Complementary Therapies; Dementia; Ginkgo biloba; Humans; Nootropic Agents; Phosphatidylserines; Phytotherapy; Plant Extracts; Plants, Medicinal; Risk Factors; Vinca Alkaloids | 1999 |
1 trial(s) available for vinpocetine and Amentia
| Article | Year |
|---|---|
[Study of the effects of vinpocetin on cognitive functions].
Topics: Administration, Oral; Adult; Aged; Cerebrovascular Circulation; Cognition; Cognitive Dysfunction; Dementia; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Nootropic Agents; Psychometrics; Quality of Life; Severity of Illness Index; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids | 2012 |
3 other study(ies) available for vinpocetine and Amentia
| Article | Year |
|---|---|
Vinpocetine loaded ultradeformable liposomes as fast dissolving microneedle patch: Tackling treatment challenges of dementia.
Topics: Animals; Cell Line, Transformed; Dementia; Female; Humans; Liposomes; Maze Learning; Microinjections; Neuroprotective Agents; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Skin Absorption; Solubility; Swine; Transdermal Patch; Vinca Alkaloids | 2020 |
Vinpocetine Improves Scopolamine Induced Learning and Memory Dysfunction in C57 BL/6J Mice.
Topics: Animals; Avoidance Learning; Behavior, Animal; Conditioning, Psychological; Dementia; Fear; Locomotion; Male; Maze Learning; Memory Disorders; Mice, Inbred C57BL; Neuroprotective Agents; Scopolamine; Vinca Alkaloids | 2016 |
Glibenclamide steady state plasma levels during concomitant vinpocetine administration in type II diabetic patients.
Topics: Blood Glucose; Dementia; Diabetes Mellitus, Type 2; Drug Interactions; Female; Glyburide; Humans; Male; Vinca Alkaloids | 1989 |